PSYC provides encouraging update on its investment in The Conscious Fund


PSYC Company

LAS VEGAS, NV, June 29, 2022 (GLOBE NEWSWIRE) — PSYC Corporation (OTCPink:PSYC) (“PSYC” or the “Company”) a media leader for the emerging medicinal psychedelics industry and the authorities behind Psychedelic Spotlight, a top Ranking psychedelic news and information platform, is pleased to announce that following a review of the information provided to the company and its audit firm, M&K CPA’s, by The Conscious Fund’s financial accountants (“TCF ), the company’s initial $125,000 investment in TCF’s portfolio of psychedelic-focused businesses completed in January 2021, realized an unrealized gain of nearly 30% by early June 2022.

The Company and its auditing firm are currently in the process of incorporating this data and information into the audit of the Company’s 2021 financial statements, which the Company believes is nearing completion.

PSYC Chief Financial Officer Craig Schlesinger touted the results, saying, “Our strategic investment in TCF has already provided PSYC with valuable leverage for the dynamic growth of medicinal psychedelic companies in sub-optimal macro and micro market conditions. . We believe that these early results in the face of economic adversity are only a harbinger of the sustainability and longevity of the sector.

“Given the ongoing challenges faced by the medicinal psychedelics industry over the past several months, we are very encouraged and pleased that our investment in TCF currently represents an unrealized gain of almost 30%,” said the PSYC CEO, David Flores. “We viewed this as a long-term investment with the potential to generate a significant return for PSYC over the next several years at a pace consistent with the growth of the industry since its inception. Despite market insistence that, in our view, the medicinal psychedelics sector is significantly undervalued, we remain as optimistic as ever about the potential for growth and long-term value present in this space.

Flores concluded, “Strategic investments like TCF demonstrate PSYC’s approach to diversifying our short- and long-term assets with the very clear intention of returning maximum value to our shareholders in the most reasonable and efficient time frame. possible”.

About PSYC Corporation (OTCPink:PSYC)

At PSYC Corporation, we integrate media, creativity, and technology to develop and deploy thought-provoking ideas and solutions that empower and transform the way we approach some of society’s most pressing issues.

PSYC has expressed its intention and commitment to position itself at the forefront of the psychedelic revolution and as a resource center for discovering and understanding the latest research and business opportunities regarding psychedelic-inspired medicines. Along with the FDA’s more open-minded approach to psychedelic drugs, and as several major US cities continue to approve the decriminalization of psilocybin, we believe investors are speculating that the psychedelic boom might be bigger than that of cannabis. PSYC is your source for news related to psychedelic-specific drug investments and cutting-edge research improving overall health, bringing this industry into the mainstream.

We are dedicated to a forward-thinking approach that embraces breakthrough new technologies and innovations, and through the vision of business development, we intend to continue to evolve into these uncharted territories as industry leaders of the future. .

Disclaimer Regarding Forward-Looking Statements:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: “anticipate”, “believe”, “continue”, “could”, “estimate”, “expect”, “intend”, “may”, “in progress”, “plan”, “potential”, “predict”, “project”, “should”, “will”, “would”, or the negative form of these terms or other comparable terms , although not all forward-looking statements contain these words. Forward-looking statements are not guarantees of future performance or results and will not necessarily be precise indications of the times at which or by which such performance or results will be achieved. Forward-looking statements are based on information available at the time they are made and involve known and unknown risks, uncertainties and other factors, including the effect of COVID-19 and the success of current vaccine delivery, the adverse effect of the Omicron variant, which may cause our results, levels of activity, performance or achievements to differ materially from the information expressed or implied by the forward-looking statements contained in this press release. This press release should be considered in conjunction with all Company filings that are disclosed on the OTC website and is not incorporated by reference into such reports.

Disclaimer: PSYC Corporation does not in any way encourage or condone the use, purchase, sale or transfer of illegal substances, and we do not encourage or condone participation in illegal activities. We support a harm reduction approach for the purposes of education and the promotion of individual and public safety. If you choose to use psychedelics, please do so responsibly.

Corporate Contact:
PSYC Society (PSYC)
(702) 761-6716
[email protected]


Comments are closed.